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Background: Transcatheter aortic valve implantation (TAVI) is a rapidly growing field. However, there is only limited data available comparing 
TAVI using the transfemoral access versus the transapical access without evidence on superiority of one over the other. In order to identify patient 
characteristics and procedural as well as clinical outcome for both techniques, we herein report the result of the German registry on transcatheter 
aortic valve implantations.
Methods: The German TAVI registry is an ongoing non-randomized national multicenter registry. As of today, 418 patients with transfemoral (fTAVI) 
and 16 patients with transapical (aTAVI) access have been included using both types of commercially available TAVI devices (CoreValve n=369, 
Edwards n=63).
Results: There are no significant differences in patient characteristics (fTAVI/aTAVI: age 81,0/82,3years; NYHA III/IV 90,4/78,6%; previous 
surgery 20,8/33,3%) except in presence of peripheral artery disease (24,1/66,7%;p<0.0001) with a higher rate of iliac/femoral stenoses 
(1.7/25.0%;p<0.0001) and kinking (10.6/38.5%;p<0.0001) in the aTAVI group. Preprocedural aortic valve area (0,7/0,7cm2), EF (52,1/54,3%), 
mean gradient (49,1/47,2mmHg) were similar. Aortic annulus diameter was smaller in the aTAVI group (24,0/22.0mm;p<0.05). Procedural success 
was 99.0/93.3% (fTAVI/aTAVI)(ns). Conversion to open surgery was needed in 2(0.5%)/1(6.5%) patients (p<0.05). Average procedure time was 
75.0/125.5min (ns). Mean duration on intensive care unit was similar with 2/2 days, however, respirator time was significantly longer in the aTAVI 
group (1.4/5.4 hours;p<0.0001). There were no significant differences in the inhospital postprocedural clinical outcome except a trend towards a 
higher mortality in the aTAVI group (8.4/23.1%;p=0.07) and a higher incidence of AV blocks type II/III in the fTAVI group (25.8/8.3%;p=0.09).
Conclusions: The ongoing German TAVI registry demonstrates a high procedural success rate and a comparable safety outcome of patients 
undergoing transfemoral TAVI versus transapical TAVI. The updated results including a 30 day clinical follow-up will be presented.
